Division 12. Controlled Dangerous Substances
Codified through Bill No. CB-018-2026, adopted May 12, 2026, effective July 24, 2026. Source: Municode, Supplement 2026 Update 2. Editorial notes and legislative history omitted.
Division 12. Controlled Dangerous Substances
Subdivision 1. General
Prince George's County, Md., Code § 14-164 (2026)
Sec. 14-164. DefinitionsLinkCopy Citation
(a)
For purposes of this Division:
(1)
A controlled dangerous substance means cocaine, phencyclidine, marijuana, or any other drug, substance, or immediate precursor in Schedules I through V of Title 5, Subtitle 4 of the Criminal Law Article, Annotated Code of Maryland, including any future amendments thereto, any synthetic drug as defined in this Section, or any substance believed to be cocaine, phencyclidine, marijuana, or any other drug, substance, or immediate precursor in Schedules I through V of Title 5, Subtitle 4 of the Criminal Law Article, Annotated Code of Maryland, including any future amendments thereto or any synthetic drug as defined in this Section.
(2)
A synthetic drug means a chemical compound that is chemically synthesized and
(A)
has been demonstrated to have binding activity at one or more cannabinoid receptors; or
(B)
is a chemical analog or isomer of a compound that has been demonstrated to have binding activity at one or more cannabinoid receptors; or
(C)
is a substance that is a cannabinoid receptor type 1 (CB 1 receptor) agonist as demonstrated by binding studies and functional assays within one of the following structural classes:
(i)
2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by akyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.
(ii)
3-(1-naphthoyl)indole or 3-(1-naphthyl)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
(iii)
3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
(iv)
1-(1-naphthylmethyl)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
(v)
3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.
(vi)
3-tetramethylcyclopropylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
(vii)
3-adamantoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
(viii)
3-adamantoyl-indazole by substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
(ix)
3-carboxamide-indazole by substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
(x)
3-carboxamide-indole by substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent; or
(D)
includes, but is not limited to, the following types:
(i)
5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (also known as CP-47,497).
(ii)
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (also known as cannabicyclohexanol or CP-44, 497 C8-homolog).
(iii)
1-pentyl-3-(1-naphthoyl)indole (also known as JWH-018 and AM678).
(iv)
1-butyl-3-(1-naphthoyl)indole (also known as JWH-073).
(v)
1-hexyl-3-(1-naphthoyl)indole (also known as JWH-019).
(vi)
1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (also known as JWH-200).
(vii)
1-pentyl-3-(2-methoxyphenylacetyl)indole (also known as JWH-250).
(viii)
1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (also known as JWH-081).
(ix)
1-pentyl-3-(4-methyl-1-naphthoyl)indole (also known as JWH-122).
(x)
1-pentyl-3-(4-chloro-1-naphthoyl)indole (also known as JWH-398).
(xi)
1-(5-fluoropentyl)-3-(1-naphthoyl)indole (also known as AM2201).
(xii)
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (also known as AM694).
(xiii)
1-pentyl-3-[(4-methoxy)-benzoyl]indole (also known as SR-19 and RCS-4).
(xiv)
1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (also known as SR-18 and RCS-8).
(xv)
1-pentyl-3-(2-chlorophenylacetyl)indole (also known as JWH-203).
(xvi)
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (also known as UR-144).
(xvii)
1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (also known as 5F-UR-144 or XLR11).
(xviii)
[1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone (also known as A796,260).
(xix)
N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide (also known as A836,339).
(xx)
1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide (also known as AKB48).
(xxi)
1(5-fluoropentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide (also known as 5F-AKB48).
(xxii)
1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole (also known as AM2233).
(xxiii)
1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalene-1-yl)methanone (also known as AM1220).
(xxiv)
1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole (also known as AM1248).
(xxv)
4-methylmethcathinone (also known as Mephedrone).
(xxvi)
3,4-methylenedioxypyrovalerone (also known as MDPV).
(xxvii)
3,4-methylenedioxymethcathinone (also known as Methylone).
(xxviii)
Naphthylpyrovalerone (also known as Naphyrone).
(xxix)
4-fluoromethcathinone (also known as Flephedrone).
(xxx)
4-methoxymethcathinone (also known as Methedrone; Bk-PMMA).
(xxxi)
N-Ethylcathinone (also known as Ethcathinone).
(xxxii)
3,4-methylenedioxyethcathinone (also known as Ethylone).
(xxxiii)
Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (also known as Butylone).
(xxxiv)
N,N-dimethylcathinone (also known as Metamfepramone).
(xxxv)
Alpha-pyrrolidinopropiophenone (also known as Alpha-PPP).
(xxxvi)
4-methoxy-alphapyrrolidinopropiophenone (also known as MOPPP).
(xxxvii)
3,4-methylenedioxy-alphapyrrolidinopropiophenone (also known as MDPPP).
(xxxviii)
Alpha-pyrrolidinovalerophenone (also known as Alpha-PVP).
(xxxix)
6,7-dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine) (also known as MDAI).
(xl)
3-fluoromethcathinone.
(xli)
4'-Methyl-α-pyrrolidinobutiophenone (also known as MPBP).
(xlii)
2-(methylamino)-propiophenone; OR alpha-(methylamino)propiophenone (also known as Methcathinone).
(xliii)
3-fluoromethcathinone (also known as 3-FMC).
(xliv)
3-methoxymethcathinone (also known as HMMC).
(xlv)
2-(methylamino)-1-phenylpropan-1-one (also known as Ephedrone).
(xlvi)
4-ethylmethcathinone (also known as 4-EMC).
(xlvii)
3,4-Dimethylmethcathinone (also known as 3,4-DMMC).
(xlviii)
Beta-Keto-N-methylbenzodioxolylpentanamine (also known as Pentylone).
(xlix)
Beta-Keto-Ethylbenzodioxolylbutanamine (also known as Eutylone).
(l)
(1-(4-methylphenyl)-2-(1-pyrrolindinyl-1-pentanone)) (also known as Pyrovalerone).
(li)
(RS)-1-(4-bromophenyl)-2-methylaminopropan-1-one (also known as Bromomethcathinone or 4-BMC or 4-Bromomethcathinone).
(lii)
(RS)-2-dimethylamino-1-phenylpropan-1-one (also known as Dimethylcathinone).
(liii)
3,4-Methylenedioxy-alpha-pyrrolidinobutiophenone (also known as MDPBP).
(liv)
Methyl-alpha-pyrrolidinohexiophenone (also known as MPHP).
(lv)
N-N-Dimethyl-3,4-methylenedioxycathinone.
(lvi)
N-N-Diethyl-3,4-methylenedioxycathinone.
(lvii)
2-Bromo-3,4-Methylenedioxypropiophenone.
(lviii)
3,4-methylendioxy-propiophenone-2-oxime.
(lix)
N-Acetyl-N-Methyl-3,4-Methylenedioxycathinone.
(lx)
N-Acetyl-N-Ethyl-3,4-Methylenedioxycathinone.
(lxi)
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (also known as 2C-E).
(lxii)
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (also known as 2C-D).
(lxiii)
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (also known as 2C-C).
(lxiv)
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (also known as 2C-I).
(lxv)
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (also known as 2C-T-2).
(lxvi)
2-[4-(Isopropylthio)-2,5- dimethoxyphenyl]ethanamine (also known as 2C-T-4).
(lxvii)
2-(2,5-Dimethoxyphenyl)ethanamine (also known as 2C- H).
(lxviii)
2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (also known as 2C-N).
(lxix)
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (also known as 2C-P).
(lxx)
the N-O-methoxybenzyl analogs of the above listed 2C compounds (also known as NBOMe compounds).
Prince George's County, Md., Code § 14-165 (2026)
Sec. 14-165. Unlawful actsLinkCopy Citation
(a)
It shall be unlawful for any person to attempt to possess any controlled dangerous substance.
(b)
It shall be unlawful to distribute or dispense a controlled dangerous substance or possess a controlled dangerous substance in a sufficient reasonable quantity to indicate under all circumstances an intent to distribute or dispense a controlled dangerous substance except as provided in Title 5 of the Criminal Law Article, Annotated Code of Maryland, including any future amendments thereto.
(c)
It shall be unlawful for any person to operate, or knowingly permit another to operate, any motor vehicle with the knowledge that the operation of the vehicle is being used or intended for use to transport, or in any manner to facilitate the transportation, sale, receipt, possession, or concealment of, any controlled dangerous substance.
(d)
It shall not be a defense to a prosecution under this Division that the substance that the person actually possessed, or that the person attempted to possess, was not a controlled dangerous substance if the person believed that the substance was a controlled dangerous substance.
(e)
Any person committing the acts enumerated in subsections (a), (b), and (c) of this Section shall be subject to the penalties enumerated in Section 14-166, which is imprisonment not to exceed six (6) months or a fine of One Thousand Dollars ($1,000.00), or both.
Prince George's County, Md., Code § 14-166 (2026)
Sec. 14-166. PenaltyLinkCopy Citation
Violation of this Division shall be punishable upon conviction by imprisonment not to exceed six (6) months or a fine of One Thousand Dollars ($1,000.00), or both.
Subdivision 2. County Building and Recreational Facilities
Prince George's County, Md., Code § 14-166.01 (2026)
Sec. 14-166.01. SignageLinkCopy Citation
(a)
All County facilities including, but not limited to, buildings, recreational facilities as well as facilities of the Prince George's County Library System, Maryland-National Capital Park and Planning Commission and the Health Department, shall have signs that contain language or symbols that the building and surrounding County property is designated as a drug free zone. The signs shall be displayed conspicuously at the entrance of each County facility.